US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.290
  • -0.030-0.90%
Close May 7 16:00 ET
629.97MMarket Cap-8.66P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.54%-64.85M
40.35%-10.32M
4.81%-20.74M
25.84%-14.5M
29.32%-19.3M
-143.06%-85.94M
-1.78%-17.29M
-16.54%-21.78M
3.62%-19.56M
-232.41%-27.3M
Net income from continuing operations
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
Operating gains losses
----
----
----
----
----
---20K
--0
----
----
----
Depreciation and amortization
-1.71%1.38M
-7.24%333K
-8.94%336K
4.09%356K
6.29%355K
-1.61%1.4M
16.94%359K
7.58%369K
-10.70%342K
-15.23%334K
Other non cash items
114.99%501K
250.97%1.4M
57.63%-200K
73.56%-326K
46.75%-377K
9.60%-3.34M
-171.93%-930K
72.27%-472K
-23.55%-1.23M
-7.93%-708K
Change In working capital
84.48%-2.83M
-115.40%-229K
26.11%-2.5M
168.88%2.76M
76.82%-2.86M
-162.35%-18.23M
-57.68%1.49M
-141.57%-3.38M
47.41%-4M
-135.50%-12.33M
-Change in receivables
-49.29%-633K
-302.78%-801K
-64.11%159K
644.00%372K
72.33%-363K
6.40%-424K
-18.22%395K
228.15%443K
107.61%50K
-216.91%-1.31M
-Change in prepaid assets
343.69%2.3M
5.10%1.15M
181.00%1.19M
206.42%116K
66.67%-156K
-138.81%-943K
-54.35%1.1M
-226.89%-1.46M
-128.61%-109K
68.94%-468K
-Change in payables and accrued expense
52.99%-2.71M
-95.70%20K
-456.04%-3.56M
437.38%2.86M
68.26%-2.02M
-210.39%-5.76M
-87.63%465K
590.69%1M
-122.54%-848K
-203.33%-6.38M
-Change in other current liabilities
3.15%-430K
20.00%-124K
-9.86%-156K
-6.85%-78K
2.70%-72K
-9.63%-444K
-25.00%-155K
-7.58%-142K
1.35%-73K
1.33%-74K
-Change in other working capital
87.27%-1.36M
-51.43%-477K
96.18%-123K
83.04%-513K
94.05%-244K
-147.49%-10.66M
89.53%-315K
-36.95%-3.22M
72.57%-3.02M
-110.57%-4.1M
Cash from discontinued investing activities
Operating cash flow
24.54%-64.85M
40.35%-10.32M
4.81%-20.74M
25.84%-14.5M
29.32%-19.3M
-143.06%-85.94M
-1.78%-17.29M
-16.54%-21.78M
3.62%-19.56M
-232.41%-27.3M
Investing cash flow
Cash flow from continuing investing activities
-54.80%22.95M
-39.66%13.41M
-214.93%-11.99M
582.10%9.83M
-29.88%11.69M
167.75%50.77M
75.25%22.23M
175.91%10.43M
110.42%1.44M
127.77%16.68M
Net PPE purchase and sale
81.58%-182K
---86K
--0
99.88%-1K
18.80%-95K
-92.97%-988K
--0
86.81%-12K
-347.40%-859K
-56.00%-117K
Net business purchase and sale
----
----
----
----
0.50%37.19M
----
----
----
----
--37M
Net investment purchase and sale
-55.31%23.13M
-39.27%13.5M
-214.80%-11.99M
19.63%47.02M
-25.70%-25.4M
169.54%51.76M
73.15%22.23M
176.51%10.44M
388.17%39.3M
66.31%-20.21M
Cash from discontinued investing activities
Investing cash flow
-54.80%22.95M
-39.66%13.41M
-214.93%-11.99M
582.10%9.83M
-29.88%11.69M
167.75%50.77M
75.25%22.23M
175.91%10.43M
110.42%1.44M
127.77%16.68M
Financing cash flow
Cash flow from continuing financing activities
69.66%52M
-62.67%1.42M
5.59%1.78M
413.92%24.37M
19.66%24.43M
-3.67%30.65M
-65.65%3.81M
-81.59%1.68M
4,096.46%4.74M
77.77%20.42M
Net common stock issuance
47.81%44.12M
-100.03%-1K
--0
371.51%22.36M
9.58%21.77M
46.88%29.85M
-65.24%3.85M
-84.44%1.4M
--4.74M
7,311.19%19.86M
Proceeds from stock option exercised by employees
890.31%7.87M
3,260.00%1.42M
522.81%1.78M
--2.01M
380.18%2.67M
-93.08%795K
-4,600.00%-45K
79.25%285K
--0
-95.05%555K
Cash from discontinued financing activities
Financing cash flow
69.66%52M
-62.67%1.42M
5.59%1.78M
413.92%24.37M
19.66%24.43M
-3.67%30.65M
-65.65%3.81M
-81.59%1.68M
4,096.46%4.74M
77.77%20.42M
Net cash flow
Beginning cash position
-14.59%26.29M
81.66%31.85M
130.86%62.79M
6.23%43.1M
-14.59%26.29M
-71.84%30.78M
-26.97%17.53M
-42.53%27.2M
-50.11%40.57M
-71.84%30.78M
Current changes in cash
323.52%10.09M
-48.32%4.52M
-219.90%-30.95M
247.24%19.7M
71.83%16.83M
94.25%-4.52M
28.98%8.74M
58.48%-9.67M
60.67%-13.38M
135.04%9.79M
Effect of exchange rate changes
-296.00%-49K
-335.71%-33K
-37.50%5K
-700.00%-8K
-425.00%-13K
213.64%25K
450.00%14K
144.44%8K
---1K
--4K
End cash Position
38.22%36.33M
38.22%36.33M
81.66%31.85M
130.86%62.79M
6.23%43.1M
-14.59%26.29M
-14.59%26.29M
-26.97%17.53M
-42.53%27.2M
-50.11%40.57M
Free cash flow
25.20%-65.03M
39.85%-10.4M
4.95%-20.74M
28.96%-14.51M
29.28%-19.39M
-142.40%-86.94M
-0.98%-17.29M
-16.15%-21.82M
0.42%-20.42M
-233.46%-27.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.54%-64.85M40.35%-10.32M4.81%-20.74M25.84%-14.5M29.32%-19.3M-143.06%-85.94M-1.78%-17.29M-16.54%-21.78M3.62%-19.56M-232.41%-27.3M
Net income from continuing operations 4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M
Operating gains losses -----------------------20K--0------------
Depreciation and amortization -1.71%1.38M-7.24%333K-8.94%336K4.09%356K6.29%355K-1.61%1.4M16.94%359K7.58%369K-10.70%342K-15.23%334K
Other non cash items 114.99%501K250.97%1.4M57.63%-200K73.56%-326K46.75%-377K9.60%-3.34M-171.93%-930K72.27%-472K-23.55%-1.23M-7.93%-708K
Change In working capital 84.48%-2.83M-115.40%-229K26.11%-2.5M168.88%2.76M76.82%-2.86M-162.35%-18.23M-57.68%1.49M-141.57%-3.38M47.41%-4M-135.50%-12.33M
-Change in receivables -49.29%-633K-302.78%-801K-64.11%159K644.00%372K72.33%-363K6.40%-424K-18.22%395K228.15%443K107.61%50K-216.91%-1.31M
-Change in prepaid assets 343.69%2.3M5.10%1.15M181.00%1.19M206.42%116K66.67%-156K-138.81%-943K-54.35%1.1M-226.89%-1.46M-128.61%-109K68.94%-468K
-Change in payables and accrued expense 52.99%-2.71M-95.70%20K-456.04%-3.56M437.38%2.86M68.26%-2.02M-210.39%-5.76M-87.63%465K590.69%1M-122.54%-848K-203.33%-6.38M
-Change in other current liabilities 3.15%-430K20.00%-124K-9.86%-156K-6.85%-78K2.70%-72K-9.63%-444K-25.00%-155K-7.58%-142K1.35%-73K1.33%-74K
-Change in other working capital 87.27%-1.36M-51.43%-477K96.18%-123K83.04%-513K94.05%-244K-147.49%-10.66M89.53%-315K-36.95%-3.22M72.57%-3.02M-110.57%-4.1M
Cash from discontinued investing activities
Operating cash flow 24.54%-64.85M40.35%-10.32M4.81%-20.74M25.84%-14.5M29.32%-19.3M-143.06%-85.94M-1.78%-17.29M-16.54%-21.78M3.62%-19.56M-232.41%-27.3M
Investing cash flow
Cash flow from continuing investing activities -54.80%22.95M-39.66%13.41M-214.93%-11.99M582.10%9.83M-29.88%11.69M167.75%50.77M75.25%22.23M175.91%10.43M110.42%1.44M127.77%16.68M
Net PPE purchase and sale 81.58%-182K---86K--099.88%-1K18.80%-95K-92.97%-988K--086.81%-12K-347.40%-859K-56.00%-117K
Net business purchase and sale ----------------0.50%37.19M------------------37M
Net investment purchase and sale -55.31%23.13M-39.27%13.5M-214.80%-11.99M19.63%47.02M-25.70%-25.4M169.54%51.76M73.15%22.23M176.51%10.44M388.17%39.3M66.31%-20.21M
Cash from discontinued investing activities
Investing cash flow -54.80%22.95M-39.66%13.41M-214.93%-11.99M582.10%9.83M-29.88%11.69M167.75%50.77M75.25%22.23M175.91%10.43M110.42%1.44M127.77%16.68M
Financing cash flow
Cash flow from continuing financing activities 69.66%52M-62.67%1.42M5.59%1.78M413.92%24.37M19.66%24.43M-3.67%30.65M-65.65%3.81M-81.59%1.68M4,096.46%4.74M77.77%20.42M
Net common stock issuance 47.81%44.12M-100.03%-1K--0371.51%22.36M9.58%21.77M46.88%29.85M-65.24%3.85M-84.44%1.4M--4.74M7,311.19%19.86M
Proceeds from stock option exercised by employees 890.31%7.87M3,260.00%1.42M522.81%1.78M--2.01M380.18%2.67M-93.08%795K-4,600.00%-45K79.25%285K--0-95.05%555K
Cash from discontinued financing activities
Financing cash flow 69.66%52M-62.67%1.42M5.59%1.78M413.92%24.37M19.66%24.43M-3.67%30.65M-65.65%3.81M-81.59%1.68M4,096.46%4.74M77.77%20.42M
Net cash flow
Beginning cash position -14.59%26.29M81.66%31.85M130.86%62.79M6.23%43.1M-14.59%26.29M-71.84%30.78M-26.97%17.53M-42.53%27.2M-50.11%40.57M-71.84%30.78M
Current changes in cash 323.52%10.09M-48.32%4.52M-219.90%-30.95M247.24%19.7M71.83%16.83M94.25%-4.52M28.98%8.74M58.48%-9.67M60.67%-13.38M135.04%9.79M
Effect of exchange rate changes -296.00%-49K-335.71%-33K-37.50%5K-700.00%-8K-425.00%-13K213.64%25K450.00%14K144.44%8K---1K--4K
End cash Position 38.22%36.33M38.22%36.33M81.66%31.85M130.86%62.79M6.23%43.1M-14.59%26.29M-14.59%26.29M-26.97%17.53M-42.53%27.2M-50.11%40.57M
Free cash flow 25.20%-65.03M39.85%-10.4M4.95%-20.74M28.96%-14.51M29.28%-19.39M-142.40%-86.94M-0.98%-17.29M-16.15%-21.82M0.42%-20.42M-233.46%-27.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 70.140
Sample Name
Sample Code
 5.950
Sample Name
Sample Code
 83.350
4
YETI Holdings
YETI
27.930
5
Teradata Corp
TDC
22.340
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 102.090
Sample Name
Sample Code
 144.300
Sample Name
Sample Code
 117.060
4
ASML Holding
ASML
700.390
5
Broadcom
AVGO
204.810
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1771
Sample Name
Sample Code
 11.350
Sample Name
Sample Code
 1.020
4
The9 Ltd
NCTY
10.610
5
Abits
ABTS
2.560
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -